The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
People rushing to buy in who thought it would go lower.
This share consolidated a treat and now heading over into the 40s.
Let's face it the RNS is on people's radars and anyone with something between the ears recognises its significance
so £750 a test.
i've done the *** packet calculations on the assumption of just capturing half of the market....and it's a lot.
much more likely obd gets bought out for a very pretty penny. over 10 years in the making this
Worth thinking about just how appealing this test will be to healthcare systems the world over.
It will literally negate the need for a huge amount of invasive biopsies and expensive time consuming MR scans. Think of all those false positives there are at present with a 60% accurate PSA test.
The cost AND time savings will be massive.
This test is worth billions imo
Few nice delayed buys popping up. Great support at this level.
The 40s won't be too far round the corner I feel.
Re read the RNS just now. It's an absolute belter. Best news I've seen out of a Pharma on AIM.
The website 94percent is very good as well. Would love to be inside and see what interest this is sparking up. I bet they've been busy on the phones this last 48hours :)
Gap filled. Cooled off as it needed to.
Will head higher from here imo. That RNS is worth an awful lot of money. Just think about how many tests are done at present with a 60% accuracy and here we are with a 95% one. Every healthcare system globally will want this for screening of patients. It saves lives and money for them and makes a ton for OBD. ..although the chance of OBD being bought out has increased an awful lot.
This RNS over time should see the SP hit £2 imo. Will be bumpy along the way but the direction is north
Remember Merciaman, they said they are in discussions with 8 of the top 10 advertisers :) ... If we are on the right track then we might get more than one of those 'game changing RNSs' in the next few months.
Hoping to add more again tomorrow as we near the newsflow period.
Nothings guaranteed of course but I've been following every bit of information out there since that Microsoft RNS and there are enough signs that programmatic ad insertion could be huge for MIRI.
And all this promise for a company with a years cash runway and 40% below recent placing price. Very favourable risk/reward in my humble opinion